Hezhong Chen

2.2k total citations · 1 hit paper
59 papers, 1.3k citations indexed

About

Hezhong Chen is a scholar working on Molecular Biology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hezhong Chen has authored 59 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 24 papers in Surgery and 20 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hezhong Chen's work include Esophageal Cancer Research and Treatment (14 papers), Esophageal and GI Pathology (10 papers) and Gastric Cancer Management and Outcomes (9 papers). Hezhong Chen is often cited by papers focused on Esophageal Cancer Research and Treatment (14 papers), Esophageal and GI Pathology (10 papers) and Gastric Cancer Management and Outcomes (9 papers). Hezhong Chen collaborates with scholars based in China, Canada and United States. Hezhong Chen's co-authors include Chunguang Li, Qijue Lu, Zhigang Li, Yue Zhao, Bentong Yu, Xiang Fei, Chaojing Lu, Yifeng Sun, Chun Guang Li and Lijie Tan and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Annals of Surgery.

In The Last Decade

Hezhong Chen

57 papers receiving 1.2k citations

Hit Papers

Multicenter, single-arm, phase II trial of camrelizumab a... 2022 2026 2023 2024 2022 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma
    2022 161 citations Jun Liu, Yang Yang et al. Journal for ImmunoTherapy of Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hezhong Chen China 21 580 534 524 300 298 59 1.3k
Simone Bertz Germany 25 1.2k 2.0× 421 0.8× 648 1.2× 460 1.5× 330 1.1× 87 1.9k
Shioto Suzuki Japan 19 468 0.8× 643 1.2× 618 1.2× 763 2.5× 189 0.6× 47 1.5k
Etsurou Bandou Japan 19 851 1.5× 675 1.3× 511 1.0× 508 1.7× 203 0.7× 27 1.7k
Katarína Kaľavská Slovakia 19 375 0.6× 188 0.4× 336 0.6× 320 1.1× 177 0.6× 72 836
Zuzana Čierna Slovakia 18 301 0.5× 194 0.4× 340 0.6× 420 1.4× 237 0.8× 47 930
Ingrid Carvo United States 11 174 0.3× 533 1.0× 391 0.7× 504 1.7× 457 1.5× 15 1.1k
Anne Gentil‐Perret France 20 153 0.3× 401 0.8× 531 1.0× 220 0.7× 252 0.8× 42 961
Mengzhong Liu China 22 896 1.5× 803 1.5× 431 0.8× 749 2.5× 335 1.1× 77 1.9k
C Sakakura Japan 17 363 0.6× 308 0.6× 354 0.7× 267 0.9× 115 0.4× 28 983
Yiping Mou China 28 916 1.6× 941 1.8× 471 0.9× 983 3.3× 315 1.1× 127 2.0k

Countries citing papers authored by Hezhong Chen

Since Specialization
Citations

This map shows the geographic impact of Hezhong Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hezhong Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hezhong Chen more than expected).

Fields of papers citing papers by Hezhong Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hezhong Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hezhong Chen. The network helps show where Hezhong Chen may publish in the future.

Co-authorship network of co-authors of Hezhong Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Hezhong Chen. A scholar is included among the top collaborators of Hezhong Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hezhong Chen. Hezhong Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Jia, Junqi Wu, Long Xu, et al.. (2023). Utility of 18F-FDG PET/CT uptake values in predicting response to neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer. Lung Cancer. 178. 20–27. 10 indexed citations
2.
Liu, Jun, Yang Yang, Zhichao Liu, et al.. (2022). Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma. Journal for ImmunoTherapy of Cancer. 10(3). e004291–e004291. 161 indexed citations breakdown →
3.
4.
Fei, Xiang, Congli Hu, Xinyu Wang, et al.. (2021). Construction of a Ferroptosis-Related Long Non-coding RNA Prognostic Signature and Competing Endogenous RNA Network in Lung Adenocarcinoma. Frontiers in Cell and Developmental Biology. 9. 751490–751490. 12 indexed citations
5.
6.
Wang, Xinyu, Qijue Lu, Fei Xiang, et al.. (2020). <p>Expression and Prognostic Value of Id-4 in Patients with Esophageal Squamous Cell Carcinoma</p>. OncoTargets and Therapy. Volume 13. 1225–1234. 4 indexed citations
7.
Wang, Xinyu, Yue Zhao, Xiang Fei, et al.. (2020). LEF1/Id3/HRAS axis promotes the tumorigenesis and progression of esophageal squamous cell carcinoma. International Journal of Biological Sciences. 16(13). 2392–2404. 6 indexed citations
8.
9.
Wang, Xinyu, et al.. (2020). The influence of thoracic duct ligation on long-term survival of patients with esophageal cancer: a propensity score-matched analysis. Journal of Thoracic Disease. 12(10). 5532–5541. 9 indexed citations
10.
Lu, Qijue, Xinyu Wang, Ji Zhu, et al.. (2020). <p>Hypoxic Tumor-Derived Exosomal Circ0048117 Facilitates M2 Macrophage Polarization Acting as miR-140 Sponge in Esophageal Squamous Cell Carcinoma</p>. OncoTargets and Therapy. Volume 13. 11883–11897. 71 indexed citations
11.
Zhao, Yue, Qijue Lu, Chunguang Li, et al.. (2019). PRMT1 regulates the tumour-initiating properties of esophageal squamous cell carcinoma through histone H4 arginine methylation coupled with transcriptional activation. Cell Death and Disease. 10(5). 359–359. 62 indexed citations
12.
Lu, Qijue, Li Xu, Chunguang Li, et al.. (2016). miR-214 inhibits invasion and migration via downregulating GALNT7 in esophageal squamous cell cancer. Tumor Biology. 37(11). 14605–14614. 32 indexed citations
13.
Xu, Li, Weilin Liao, Qijue Lu, et al.. (2016). ANG Promotes Proliferation and Invasion of the Cell of Lung Squamous Carcinoma by Directly Up-Regulating HMGA2. Journal of Cancer. 7(7). 862–871. 16 indexed citations
14.
Lu, Chaojing, et al.. (2016). Identification of differentially expressed genes between lung adenocarcinoma and lung squamous cell carcinoma by gene expression profiling. Molecular Medicine Reports. 14(2). 1483–1490. 21 indexed citations
15.
Yue, Hui, et al.. (2015). Protein arginine methyltransferase 1 promoted the growth and migration of cancer cells in esophageal squamous cell carcinoma. Tumor Biology. 37(2). 2613–2619. 15 indexed citations
16.
Zhang, Caiyun, Shicai Chen, Minhui Zhu, et al.. (2014). Combined use of gastric pull-up and pectoralis major flaps for massive defects after total laryngopharyngoesophagectomy in patients with advanced hypopharyngeal carcinoma. European Archives of Oto-Rhino-Laryngology. 272(11). 3557–3564. 7 indexed citations
17.
Zhao, Tiejun, Hezhong Chen, Hai Jin, et al.. (2013). 肺腫瘍化学療法のための経口抗腫瘍薬キャリアとしてのDDAB修飾TPGS-b-(PLC-ran-PGA)ナノ粒子. NANO. 8(2). 1–1350014. 5 indexed citations
18.
Zou, Liang-jian, et al.. (2012). Catamenial pneumothorax associated with multiple diaphragmatic perforations and pneumoperitoneum in a reproductive woman. Journal of the Formosan Medical Association. 113(6). 385–387. 6 indexed citations
19.
Li, Chunguang, Zhigang Li, Tiejun Zhao, et al.. (2012). Clinicopathological and Prognostic Significance of Survivin Over-Expression in Patients with Esophageal Squamous Cell Carcinoma: A Meta-Analysis. PLoS ONE. 7(9). e44764–e44764. 28 indexed citations
20.
Li, Chun Guang, Yan Yan, Weidan Ji, et al.. (2012). OCT4 Positively Regulates Survivin Expression to Promote Cancer Cell Proliferation and Leads to Poor Prognosis in Esophageal Squamous Cell Carcinoma. PLoS ONE. 7(11). e49693–e49693. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Simone Bertz Breakdown of academic impact, for papers by Shioto Suzuki Breakdown of academic impact, for papers by Etsurou Bandou Breakdown of academic impact, for papers by Katarína Kaľavská Breakdown of academic impact, for papers by Zuzana Čierna Breakdown of academic impact, for papers by Ingrid Carvo Breakdown of academic impact, for papers by Anne Gentil‐Perret Breakdown of academic impact, for papers by Mengzhong Liu Breakdown of academic impact, for papers by C Sakakura Breakdown of academic impact, for papers by Yiping Mou
Rankless by CCL
2026